Spots Global Cancer Trial Database for peritoneal carcinoma
Every month we try and update this database with for peritoneal carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum | NCT04022213 | Desmoplastic Sm... Peritoneal Canc... Peritoneal Carc... | 131 I-omburtama... WAP-IMRT | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma | NCT01035658 | Ovarian Cancer Fallopian Tube ... Peritoneal Carc... | Pazopanib Doxil | 18 Years - | SCRI Development Innovations, LLC | |
| Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer | NCT02199171 | FIGO Stage IIC-... Fallopian Tube ... Peritoneal Carc... | carboplatin | 18 Years - | University of California, Irvine | |
| Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2) | NCT03931304 | Peritoneal Carc... Ovarian Cancer | Cytoreductive s... | 18 Years - 95 Years | Hospices Civils de Lyon | |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation | |
| Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers | NCT06435689 | Colon Cancer Peritoneal Carc... | Sampling | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer | NCT00181688 | Ovarian Cancer Peritoneal Carc... Tubal Carcinoma | Iressa (ZD1839) Arimidex (Anast... | 18 Years - | Massachusetts General Hospital | |
| A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors | NCT04442126 | Advanced Solid ... Non-small Cell ... Colorectal Canc... Squamous Cell C... Ovarian Carcino... Peritoneal Carc... Fallopian Tube ... Head and Neck S... Triple Negative... | NM21-1480 | 18 Years - | Numab Therapeutics AG | |
| Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC | NCT03732781 | Peritoneal Carc... Colorectal Carc... | Radspherin | 18 Years - | Oncoinvent AS | |
| Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery | NCT04498117 | Carcinoma, Ovar... Ovarian Neoplas... Ovarian Cancer Ovarian Serous ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Peritoneal Canc... Peritoneal Carc... Peritoneal Neop... | Oregovomab Paclitaxel Carboplatin Placebo Carboplatin | 18 Years - | CanariaBio Inc. | |
| Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer | NCT00511992 | Advanced Ovaria... Primary Periton... Ovarian Carcino... | Avastin Paclitaxel Cisplatin | 18 Years - | University of Oklahoma | |
| A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum | NCT04022213 | Desmoplastic Sm... Peritoneal Canc... Peritoneal Carc... | 131 I-omburtama... WAP-IMRT | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| ITIL-306 in Advanced Solid Tumors | NCT05397093 | Epithelial Ovar... Non-small Cell ... Renal Cell Carc... | ITIL-306 | 18 Years - | Instil Bio | |
| Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy | NCT00377429 | Ovarian Cancer | catumaxomab | 18 Years - | Neovii Biotech | |
| Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy | NCT05763199 | Ovarian Epithel... Fallopian Tube ... Peritoneal Carc... | AHCC Chemotherapy Placebo | 18 Years - | University of California, Davis | |
| Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy | NCT04415944 | Ovarian Epithel... Ovarian Epithel... Ovarian Epithel... Stage I Fallopi... Stage II Fallop... Stage III Fallo... Peritoneal Carc... | Second look lap... HIPEC with Carb... FACT-O Quality ... | 18 Years - | Wake Forest University Health Sciences | |
| Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer | NCT00511992 | Advanced Ovaria... Primary Periton... Ovarian Carcino... | Avastin Paclitaxel Cisplatin | 18 Years - | University of Oklahoma | |
| Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators | NCT05932719 | Hepatocellular ... Peritoneal Carc... | COLLAT-COVID is... | 18 Years - | Hospices Civils de Lyon | |
| A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors | NCT04442126 | Advanced Solid ... Non-small Cell ... Colorectal Canc... Squamous Cell C... Ovarian Carcino... Peritoneal Carc... Fallopian Tube ... Head and Neck S... Triple Negative... | NM21-1480 | 18 Years - | Numab Therapeutics AG | |
| Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy | NCT04415944 | Ovarian Epithel... Ovarian Epithel... Ovarian Epithel... Stage I Fallopi... Stage II Fallop... Stage III Fallo... Peritoneal Carc... | Second look lap... HIPEC with Carb... FACT-O Quality ... | 18 Years - | Wake Forest University Health Sciences | |
| CAR T Cells in Mesothelin Expressing Cancers | NCT03054298 | Lung Adenocarci... Ovarian Cancer Peritoneal Carc... Fallopian Tube ... Mesotheliomas P... Mesothelioma Pe... | huCART-meso cel... | 18 Years - | University of Pennsylvania | |
| Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer | NCT04158349 | Colorectal Canc... Appendiceal Can... Peritoneal Carc... | Oxaliplatin mFOLFIRI | 18 Years - | University of Utah | |
| Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer | NCT00047632 | Ovarian Carcino... Peritoneal Carc... | Interferon gamm... | - | InterMune | |
| Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer | NCT02125513 | Ovarian Cancer Fallopian Tube ... Peritoneal Carc... | carboplatin and... | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators | NCT05932719 | Hepatocellular ... Peritoneal Carc... | COLLAT-COVID is... | 18 Years - | Hospices Civils de Lyon | |
| Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer | NCT05605535 | Ovarian Neoplas... Ovarian Cancer Fallopian Tube ... Peritoneal Carc... Ovarian Serous ... | Oregovomab Paclitaxel Carboplatin Placebo | 18 Years - | CanariaBio Inc. | |
| A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma | NCT00434642 | Ovarian Cancer | Carboplatin Gemcitabine Bevacizumab Placebo | 18 Years - | Genentech, Inc. | |
| Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites | NCT00326885 | Malignant Ascit... | catumaxomab | 18 Years - | Neovii Biotech | |
| Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer | NCT05605535 | Ovarian Neoplas... Ovarian Cancer Fallopian Tube ... Peritoneal Carc... Ovarian Serous ... | Oregovomab Paclitaxel Carboplatin Placebo | 18 Years - | CanariaBio Inc. | |
| Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma | NCT01035658 | Ovarian Cancer Fallopian Tube ... Peritoneal Carc... | Pazopanib Doxil | 18 Years - | SCRI Development Innovations, LLC | |
| WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer | NCT01144442 | Ovarian Cancer Fallopian Tube ... Peritoneal Carc... | Hyperthermic in... Isotonic saline... Surgery Carboplatin Paclitaxel | 16 Years - 90 Years | Masonic Cancer Center, University of Minnesota | |
| Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2) | NCT03931304 | Peritoneal Carc... Ovarian Cancer | Cytoreductive s... | 18 Years - 95 Years | Hospices Civils de Lyon | |
| Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC | NCT03732781 | Peritoneal Carc... Colorectal Carc... | Radspherin | 18 Years - | Oncoinvent AS | |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation | |
| Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers | NCT06435689 | Colon Cancer Peritoneal Carc... | Sampling | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer | NCT02125513 | Ovarian Cancer Fallopian Tube ... Peritoneal Carc... | carboplatin and... | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2) | NCT03931304 | Peritoneal Carc... Ovarian Cancer | Cytoreductive s... | 18 Years - 95 Years | Hospices Civils de Lyon | |
| Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy | NCT00377429 | Ovarian Cancer | catumaxomab | 18 Years - | Neovii Biotech | |
| Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer | NCT04158349 | Colorectal Canc... Appendiceal Can... Peritoneal Carc... | Oxaliplatin mFOLFIRI | 18 Years - | University of Utah |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
